Increased frequency of circulating invariant natural killer T cells in malignant pleural mesothelioma patients.
Invariant natural killer T (iNKT) cells are a distinct subset of human T cells, which expresses an invariant T cell receptor Vα24 Jα18 and recognizes glycolipid antigens in the context of CD1d molecules. iNKT cells exert pivotal regulatory roles in many immune responses, including antitumor immune responses. Alterations in iNKT cell frequency, phenotype, and activation state have been reported in cancer patients. No data are available on the iNKT cells in malignant pleural mesothelioma (MPM), a rare, but very aggressive, malignancy of the pleura with a very poor prognosis. Here, we studied the frequency, phenotype, and cytokine profile of circulating iNKT cells in MPM patients, and correlated results with tumor histological types (epithelioid, sarcomatoid, biphasic) and clinical stages (I-III). We found that the iNKT cell frequency was significantly increased in MPM patients with epithelioid and sarcomatoid types in comparison with healthy volunteers (HV); only three biphasic mesotheliomas were available in this study, thus no conclusions can be drawn for this MPM type. The increased frequency significantly correlates with the clinical stage of tumor with the highest value at the stage III in both epithelioid and sarcomatoid subtypes. According to the histological types, we measured changes in the frequencies of CD4⁺ CD8⁺ (DP) and CD4⁻CD8⁻ (DN), but not in the cytokine profiles (IFN-γ/IL-4 expression). These results demonstrate that the frequency of iNKT cells is increased in MPM patients and that this increase correlates with MPM type and stage.
Department of Pharmaceutical Sciences, University of "Piemonte Orientale Amedeo Avogadro", Novara, Italy.
Emanuela
E
Altomare
Silvia
S
Fallarini
Gabriele
G
Biaggi
Elisabetta
E
Gattoni
Mario
M
Botta
Grazia
G
Lombardi
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015703:Antigens, CD / Q000378:metabolism; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000097:blood / Q000378:metabolism; D015847:Interleukin-4 / Q000097:blood / Q000378:metabolism; D018655:Lymphocyte Count; D008297:Male; D008654:Mesothelioma / Q000097:blood / Q000276:immunology / Q000473:pathology*; D008875:Middle Aged; D055611:Natural Killer T-Cells / Q000378:metabolism / Q000473:pathology*; D009367:Neoplasm Staging; D010641:Phenotype; D010997:Pleural Neoplasms / Q000097:blood / Q000276:immunology / Q000473:pathology*
D015703:Antigens, CD; C508598:IL4 protein, human; D015847:Interleukin-4; D007371:Interferon-gamma